These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

544 related items for PubMed ID: 23359331

  • 1. Reactivation of occult hepatitis B virus infection following cytotoxic lymphoma therapy in an anti-HBc negative patient.
    Feeney SA, McCaughey C, Watt AP, Agnaf MR, McDougall N, Wend UC, Gerlich WH, Coyle PV.
    J Med Virol; 2013 Apr; 85(4):597-601. PubMed ID: 23359331
    [Abstract] [Full Text] [Related]

  • 2. Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer.
    Borentain P, Colson P, Coso D, Bories E, Charbonnier A, Stoppa AM, Auran T, Loundou A, Motte A, Ressiot E, Norguet E, Chabannon C, Bouabdallah R, Tamalet C, Gérolami R.
    J Viral Hepat; 2010 Nov; 17(11):807-15. PubMed ID: 20002298
    [Abstract] [Full Text] [Related]

  • 3. Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis.
    Koo YX, Tay M, Teh YE, Teng D, Tan DS, Tan IB, Tai DW, Quek R, Tao M, Lim ST.
    Ann Hematol; 2011 Oct; 90(10):1219-23. PubMed ID: 21520001
    [Abstract] [Full Text] [Related]

  • 4. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
    Lan JL, Chen YM, Hsieh TY, Chen YH, Hsieh CW, Chen DY, Yang SS.
    Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
    [Abstract] [Full Text] [Related]

  • 5. Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma.
    Wu JM, Huang YH, Lee PC, Lin HC, Lee SD.
    J Clin Gastroenterol; 2009 Oct; 43(5):496-8. PubMed ID: 19247200
    [Abstract] [Full Text] [Related]

  • 6. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
    Yeo W, Chan TC, Leung NW, Lam WY, Mo FK, Chu MT, Chan HL, Hui EP, Lei KI, Mok TS, Chan PK.
    J Clin Oncol; 2009 Feb 01; 27(4):605-11. PubMed ID: 19075267
    [Abstract] [Full Text] [Related]

  • 7. Prospective analysis of hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma after rituximab combination chemotherapy.
    Niitsu N, Hagiwara Y, Tanae K, Kohri M, Takahashi N.
    J Clin Oncol; 2010 Dec 01; 28(34):5097-100. PubMed ID: 20837949
    [Abstract] [Full Text] [Related]

  • 8. Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study.
    Seto WK, Chan TS, Hwang YY, Wong DK, Fung J, Liu KS, Gill H, Lam YF, Lie AK, Lai CL, Kwong YL, Yuen MF.
    J Clin Oncol; 2014 Nov 20; 32(33):3736-43. PubMed ID: 25287829
    [Abstract] [Full Text] [Related]

  • 9. Reactivation of hepatitis B virus in patients with undetectable HBsAg undergoing chemotherapy for malignant lymphoma or multiple myeloma.
    Matsui T, Kang JH, Nojima M, Tomonari A, Aoki H, Yamazaki H, Yane K, Tsuji K, Andoh S, Andoh S, Sakai H, Maemori M, Maguchi H, Tanaka Y.
    J Med Virol; 2013 Nov 20; 85(11):1900-6. PubMed ID: 23926082
    [Abstract] [Full Text] [Related]

  • 10. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment].
    Zhang RF, Liu L, Zheng YF, Shen YZ, Chen J, Gu SM, Wang JR, Lu HZ.
    Zhonghua Gan Zang Bing Za Zhi; 2013 Mar 20; 21(3):189-91. PubMed ID: 23967739
    [Abstract] [Full Text] [Related]

  • 11. Reactivation of hepatitis B virus after rituximab-containing treatment in patients with CD20-positive B-cell lymphoma.
    Matsue K, Kimura S, Takanashi Y, Iwama K, Fujiwara H, Yamakura M, Takeuchi M.
    Cancer; 2010 Oct 15; 116(20):4769-76. PubMed ID: 20597091
    [Abstract] [Full Text] [Related]

  • 12. Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study Group.
    Kim SJ, Hsu C, Song YQ, Tay K, Hong XN, Cao J, Kim JS, Eom HS, Lee JH, Zhu J, Chang KM, Reksodiputro AH, Tan D, Goh YT, Lee J, Intragumtornchai T, Chng WJ, Cheng AL, Lim ST, Suh C, Kwong YL, Kim WS.
    Eur J Cancer; 2013 Nov 15; 49(16):3486-96. PubMed ID: 23910494
    [Abstract] [Full Text] [Related]

  • 13. The difficulties of managing severe hepatitis B virus reactivation.
    Roche B, Samuel D.
    Liver Int; 2011 Jan 15; 31 Suppl 1():104-10. PubMed ID: 21205146
    [Abstract] [Full Text] [Related]

  • 14. Randomized controlled trial of entecavir prophylaxis for rituximab-associated hepatitis B virus reactivation in patients with lymphoma and resolved hepatitis B.
    Huang YH, Hsiao LT, Hong YC, Chiou TJ, Yu YB, Gau JP, Liu CY, Yang MH, Tzeng CH, Lee PC, Lin HC, Lee SD.
    J Clin Oncol; 2013 Aug 01; 31(22):2765-72. PubMed ID: 23775967
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation.
    Giaccone L, Festuccia M, Marengo A, Resta I, Sorasio R, Pittaluga F, Fiore F, Boccadoro M, Rizzetto M, Bruno B, Marzano A.
    Biol Blood Marrow Transplant; 2010 Jun 01; 16(6):809-17. PubMed ID: 20060484
    [Abstract] [Full Text] [Related]

  • 16. Genotype, phylogenetic analysis, and transmission pattern of occult hepatitis B virus (HBV) infection in families of asymptomatic HBsAg carriers.
    Datta S, Banerjee A, Chandra PK, Chowdhury A, Chakravarty R.
    J Med Virol; 2006 Jan 01; 78(1):53-9. PubMed ID: 16299727
    [Abstract] [Full Text] [Related]

  • 17. Spontaneous reactivation of hepatitis B virus (HBV) infection in patients with resolved or occult HBV infection.
    Kamitsukasa H, Iri M, Tanaka A, Nagashima S, Takahashi M, Nishizawa T, Okamoto H.
    J Med Virol; 2015 Apr 01; 87(4):589-600. PubMed ID: 25612181
    [Abstract] [Full Text] [Related]

  • 18. High levels of serum hepatitis B virus DNA in patients with 'anti-HBc alone': role of HBsAg mutants.
    Launay O, Masurel J, Servant-Delmas A, Basse-Guérineau AL, Méritet JF, Laperche S, Sogni P, Rosenberg AR.
    J Viral Hepat; 2011 Oct 01; 18(10):721-9. PubMed ID: 21914087
    [Abstract] [Full Text] [Related]

  • 19. Molecular characterization of occult hepatitis B cases in Greek blood donors.
    Katsoulidou A, Paraskevis D, Magiorkinis E, Moschidis Z, Haida C, Hatzitheodorou E, Varaklioti A, Karafoulidou A, Hatzitaki M, Kavallierou L, Mouzaki A, Andrioti E, Veneti C, Kaperoni A, Zervou E, Politis C, Hatzakis A.
    J Med Virol; 2009 May 01; 81(5):815-25. PubMed ID: 19319945
    [Abstract] [Full Text] [Related]

  • 20. Prospective evaluation of seropositive occult hepatitis B viral infection in lymphoma patients receiving chemotherapy.
    Cheung WI, Lin SY, Leung VK, Fung KS, Lam YK, Lo FH, Chau TN.
    Hong Kong Med J; 2011 Oct 01; 17(5):376-80. PubMed ID: 21979474
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.